EdgarLookup

Peterson Amy C.

Insider transactions at 3 companies

This page shows all SEC Form 4 filings attributed to Peterson Amy C.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

EXEL CTMX BEIGF
Company Title Type Shares Price Value Date
EXEL EVP Prod Dev & Med Aff & CMO Option Exercise 40,000 $21.75 $870,000 May 16, 2025
EXEL EVP Prod Dev & Med Aff & CMO Award / Grant 159,383 Mar 31, 2025
EXEL EVP Prod Dev & Med Aff & CMO Award / Grant 52,192 Feb 26, 2025
EXEL EVP Prod Dev & Med Aff & CMO Tax Withholding 27,224 $35.05 $954,201 Nov 15, 2024
EXEL EVP Prod Dev & Med Aff & CMO Award / Grant 82,121 Feb 23, 2024
EXEL EVP Prod Dev & Med Aff & CMO Award / Grant 240,000 Aug 24, 2023
CTMX EVP, Chief Development Officer Sale 4,257 $1.98 $8,429 Mar 16, 2023
CTMX EVP, Chief Development Officer Sale 7,463 $1.42 $10,597 Jul 19, 2022
CTMX EVP, Chief Development Officer Award / Grant 40,000 Feb 2, 2022
CTMX EVP, Chief Development Officer Award / Grant 3,320 $6.09 $20,219 May 31, 2021
CTMX EVP, Chief Development Officer Award / Grant 3,101 $6.39 $19,815 Nov 30, 2020
BEIGF CMO, Immuno-oncology Sale 2,296 $136.24 $312,807 Dec 17, 2018
BEIGF CMO, Immuno-oncology Option Exercise 13,222 $29.10 $384,760 Nov 12, 2018
BEIGF CMO, Immuno-oncology Sale 2,300 $168.94 $388,562 Aug 23, 2018
BEIGF CMO, Immuno-oncology Award / Grant 44,564 Jun 26, 2018
BEIGF CMO, Immuno-oncology Sale 1,201 $83.31 $100,055 Nov 13, 2017
BEIGF CMO, Immuno-oncology Tax Withholding 28,185 $5.39 $151,917 Aug 22, 2017
BEIGF CMO, Immuno-oncology Award / Grant 300,000 Aug 22, 2016